Epilepsy management involves a range of strategies, from anti-seizure medications to advanced surgical and dietary therapies, all aimed at controlling seizures and improving quality of life.

Epilepsy is a chronic neurological disorder affecting approximately 65 million people worldwide [4]. It is characterized by recurrent, unprovoked seizures, which are sudden, uncontrolled disturbances in the brain's electrical activity. The primary goal of epilepsy treatment is to achieve seizure freedom or significantly reduce seizure frequency, while minimizing side effects and improving the patient's overall quality of life.

Understanding Anti-Seizure Medications (ASMs)

Anti-seizure medications (ASMs), also known as anti-epileptic drugs (AEDs), are the cornerstone of epilepsy treatment. There are more than 20 ASMs commercially available in the United States, with some sources indicating over 30 options globally [1, 3, 4, 5]. These medications work by stabilizing brain activity to prevent seizures. For about two-thirds of individuals with epilepsy, ASMs can successfully control seizures, allowing them to become seizure-free [4].

Over the years, newer generations of ASMs have been developed. While their efficacy may be similar to older medications, these newer drugs often offer a more favorable tolerability profile, making them easier for patients to manage [3]. The selection of an appropriate ASM is a complex decision, often tailored to the individual's specific type of epilepsy, their age, other health conditions, and potential drug interactions [2, 3]. For instance, treatment considerations may differ for elderly patients, pregnant individuals, or those with co-existing conditions like HIV infection or tumors [3].

Addressing Drug-Resistant Epilepsy

Despite the wide array of ASMs available, approximately one-third of patients with epilepsy continue to experience persistent seizures, a condition known as drug-resistant epilepsy (DRE) [2, 4]. DRE carries a significant burden, including comorbidities and an increased risk of premature death [2]. For these individuals, exploring treatment options beyond standard medications becomes crucial.

The challenge of DRE has spurred the development of alternative therapeutic strategies, moving towards a more holistic and precision medicine approach [2]. This involves a comprehensive evaluation of the patient to determine the most suitable intervention, which may include non-pharmacological methods [2].

Non-Pharmacological Treatment Approaches

When ASMs are insufficient, several non-pharmacological treatments can be considered:

Surgical Interventions: Epilepsy surgery aims to remove or disconnect the area of the brain causing seizures. Techniques include resective surgery, disconnection procedures, and neuromodulation devices like vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS) [5]. Minimally invasive approaches, such as magnetic resonance-guided laser interstitial thermal therapy, have shown promising results, with one large pediatric series reporting a 68% seizure-free rate at two years [6].
Dietary Therapies: The ketogenic diet, a high-fat, low-carbohydrate, adequate-protein diet, has proven effective for some patients, particularly in pediatric epilepsy. It can lead to a greater than 50% reduction in seizures for some individuals, demonstrating superiority over conventional management in certain cases [6]. However, long-term use may be associated with specific challenges [6].
Cannabidiol (CBD): A highly purified, plant-derived cannabidiol oral solution (Epidiolex®/Epidyolex®) is an established treatment for seizures associated with specific severe developmental and epileptic encephalopathies, including Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex [8].

Emerging Therapies and Future Directions

The field of epilepsy treatment is continuously evolving, with significant research focused on novel therapeutic strategies. A key trend is the move towards precision medicine, which involves tailoring treatments based on a comprehensive understanding of each patient's unique condition, including the specific type of epilepsy [2].

Future directions include disease-modifying treatments that target the underlying causes of epilepsy, rather than just managing symptoms. Examples include antisense oligonucleotides and adeno-associated virus-mediated gene replacement therapies, which have shown promise in early trials for some epilepsy types, reporting moderate seizure reduction [6]. Researchers are also developing new anti-seizure agents that target novel mechanisms within the brain [5].

Challenges and Personalized Management

The multitude of available treatment options can be challenging for clinicians, especially those who are not subspecialists in epilepsy [1]. Many complex clinical questions lack definitive answers from large-scale randomized controlled studies, leading clinicians to often consult experts in the field [1].

Effective epilepsy management requires a personalized approach, considering the patient as a whole [2]. This involves not only selecting the most suitable drug or intervention but also addressing potential comorbidities and specific life circumstances [3]. Furthermore, disparities in access to essential anti-seizure medications and dietary therapies, particularly in lower-income regions, remain a significant barrier to optimal care globally [7]. Consulting with an epilepsy specialist is crucial for navigating these complex treatment decisions and ensuring the best possible outcomes.

Sources

[1] Epilepsy treatment in adults and adolescents: Expert opinion, 2016. https://pubmed.ncbi.nlm.nih.gov/28237319/
[2] New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment. https://pubmed.ncbi.nlm.nih.gov/34950099/
[3] Novel Treatment and New Drugs in Epilepsy Treatment. https://pubmed.ncbi.nlm.nih.gov/29076416/
[4] Prognosis of people with focal epilepsy treated with anti-seizure medications (ASMs): a narrative review of current evidence and future directions. https://pubmed.ncbi.nlm.nih.gov/41425832/
[5] Epileptogenesis and Epilepsy Treatment: Advances in Mechanistic Understanding, Therapeutic Approaches, and Future Perspectives. https://pubmed.ncbi.nlm.nih.gov/41683601/
[6] Treatment of pediatric epilepsy. https://pubmed.ncbi.nlm.nih.gov/41726582/
[7] Challenges in epilepsy management in the Eastern Mediterranean (Part I): Disparities in pharmacological treatment and ketogenic diet access. https://pubmed.ncbi.nlm.nih.gov/41891746/
[8] A systematic review of highly purified cannabidiol in developmental and epileptic encephalopathies and complex treatment-resistant epilepsies: Changes in seizure frequency and adverse events. https://pubmed.ncbi.nlm.nih.gov/41558068/

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.